Epidemiological and economic burden of Clostridium difficile in the United States: estimates from a modeling approach
Author:
Funder
Merck
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases
Link
http://link.springer.com/content/pdf/10.1186/s12879-016-1610-3
Reference42 articles.
1. Gupta SB, Dubberke ER. Overview and changing epidemiology of Clostridium difficile infection. Seminars in Colon and Rectal Surgery. 2014;25:118–23.
2. Khan FY, Elzouki AN. Clostridium difficile infection: a review of the literature. Asian Pac J Trop Med. 2014;7S1:S6–13.
3. Johnson S. Recurrent Clostridium difficile infection: A review of risk factors, treatments, and outcomes. J Infect. 2009;58:403–10.
4. Loo VG, Bourgault AM, Poirier L, Lamothe F, Michaud S, Turgeon N, Toye B, Beaudoin A, Frost EH, Gilca R, et al. Host and pathogen factors for Clostridium difficile infection and colonization. N Engl J Med. 2011;365:1693–703.
5. Cornely OA, Miller MA, Louie TJ, Crook DW, Gorbach SL. Treatment of First Recurrence of Clostridium difficile Infection: Fidaxomicin Versus Vancomycin. Clin Infect Dis. 2012;55 Suppl 2:S154–61.
Cited by 136 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Diverse Sources and Latent Reservoirs of Community-Associated Clostridioides difficile Infection;Clinical Infectious Diseases;2024-08-31
2. Antibiotic use and risk of Clostridioides difficile infection in patients with inflammatory bowel disease;Journal of Gastroenterology and Hepatology;2024-08-15
3. Metagenome-assembled genomes (MAGs) suggest an acetate-driven protective role in gut microbiota disrupted by Clostridioides difficile;Microbiological Research;2024-08
4. A Retrospective Analysis of the Clinical Effectiveness of Tigecycline in the Treatment of Clostridioides difficile-Associated Diarrhea;Pharmacoepidemiology;2024-06-13
5. Unique growth and morphology properties of Clade 5Clostridioides difficilestrains revealed by single-cell time-lapse microscopy;2024-02-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3